Valeant Pharmaceuticals International, Inc. 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Aug 9, 2011
Insider Transaction Report
Form 4
STEVENSON KATHARINE BERGHUIS
Director
Transactions
- Purchase
Common Stock, no par value
2011-08-08$39.73/sh+1,000$39,730→ 10,397 total
Footnotes (2)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $39.72 to $39.74, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]Includes 5,000 common shares and 4,397 RSUs that were previously reported.